Evidence map›Paper›PMID 35356547›Full record

ArticleComputational and structural biotechnology journal2022

OmicsView: Omics data analysis through interactive visual analytics.

Fergal Casey, Soumya Negi, Jing Zhu, Yu H Sun, Maria Zavodszky, Derrick Cheng, Dongdong Lin, Sally John, Michelle A Penny, David Sexton and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Computational and structural biotechnology journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fergal CaseyTranslational Biology, Research Development, Biogen, Inc., Cambridge, MA 02142, USA.
Soumya NegiTranslational Biology, Research Development, Biogen, Inc., Cambridge, MA 02142, USA.
Jing ZhuTranslational Biology, Research Development, Biogen, Inc., Cambridge, MA 02142, USA.
Yu H SunTranslational Biology, Research Development, Biogen, Inc., Cambridge, MA 02142, USA.
Maria ZavodszkyTranslational Biology, Research Development, Biogen, Inc., Cambridge, MA 02142, USA.
Derrick ChengBioInfoRx, Inc., 510 Charmany Dr, Suite 275A, Madison, WI 53719, USA.
Dongdong LinTranslational Biology, Research Development, Biogen, Inc., Cambridge, MA 02142, USA.
Sally JohnTranslational Biology, Research Development, Biogen, Inc., Cambridge, MA 02142, USA.
Michelle A PennyTranslational Biology, Research Development, Biogen, Inc., Cambridge, MA 02142, USA.
David SextonTranslational Biology, Research Development, Biogen, Inc., Cambridge, MA 02142, USA.
Baohong ZhangTranslational Biology, Research Development, Biogen, Inc., Cambridge, MA 02142, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With advances in NGS technologies, transcriptional profiling of human tissue across many diseases is becoming more routine, leading to the generation of petabytes of data deposited in public repositories. There is a need for bench scientists with little computational expertise to be able to access and mine this data to understand disease pathology, identify robust biomarkers of disease and the effect of interventions (

Indexed as

DEG, Differentially Expressed GeneExpression databasesExpression profilingMeta-analysisNGS, Next Generation SequencingRNAseqRNASeq, RNA SequencingVisual analytics

Identifiers

PMID35356547
PMCPMC8924308

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.